Sarepta Therapeutics (BSP:S1RP34) Deferred Tax : R$0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Sarepta Therapeutics Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Sarepta Therapeutics's change in deferred tax for the three months ended in Mar. 2024 was R$0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2024 was R$0 Mil.

Sarepta Therapeutics Deferred Tax Historical Data

The historical data trend for Sarepta Therapeutics's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sarepta Therapeutics Deferred Tax Chart

Sarepta Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Deferred Tax

Get a 7-Day Free Trial

Sarepta Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Deferred Tax	Get a 7-Day Free Trial															-	-	-	-	-

Sarepta Therapeutics Deferred Tax Calculation

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0 Mil.

Sarepta Therapeutics Deferred Tax Related Terms

Thank you for viewing the detailed overview of Sarepta Therapeutics's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Sarepta Therapeutics (BSP:S1RP34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sarepta Therapeutics Inc (BSP:S1RP34) » Definitions » Deferred Tax

Comparable Companies

Traded in Other Exchanges

SRPT:USA AB3A:Germany

Address

215 First Street, Suite 415, Cambridge, MA, USA, 02142

Website

https://www.sarepta.com

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.

Sarepta Therapeutics (BSP:S1RP34) Headlines

No Headlines